Real-world data (RWD) used to monitor COVID-19 vaccine safety

  • The oncology community has stepped up in a major way to reach out to its life science partners, sharing its early successes with RWD to maximize the utility of our data resources
  • “Sustained collaboration between life science stakeholders, data companies, and their clinical partners will be key to end the pandemic.  It’s vital for everyone to contribute their experiences to the shared fight against COVID-19, especially as new variants spread across the globe.”

Dr Miruna Sasu, Chief Strategy Officer COTA

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit and contact us at

ref: AUG2021BR001